Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Rebecca R Crawford"'
Autor:
Tamar Sapir, Sara M. Tolaney, Rebecca R Crawford, Joyce O'Shaughnessy, Laurence F. Greene, Tariqa Ackbarali, Jeffrey D. Carter
Publikováno v:
Cancer Research. 80:P1-15
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) offer the potential to significantly improve outcomes for women with HR+, HER2- breast cancer. However, given the relative short time period of their availability, appropriate evidence-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cf3436b86e55c866f8e8a1c77c998c7
https://doi.org/10.1158/1538-7445.sabcs19-p1-15-05
https://doi.org/10.1158/1538-7445.sabcs19-p1-15-05
Publikováno v:
Gynecologic Oncology. 162:S174
Objectives: To identify areas for improvement and design system-based strategies to address challenges in the provision of quality ovarian cancer care, we undertook a quality improvement (QI) program at 2 large US-based hospital systems. Methods: At
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b72e5e7f404fac891edd4b1ba1c9a1c
https://doi.org/10.1016/s0090-8258(21)00973-2
https://doi.org/10.1016/s0090-8258(21)00973-2
Autor:
Taral Patel, Karim Chamie, Jeffrey D. Carter, Tamar Sapir, Rebecca R Crawford, Manojkumar Bupathi, Sarah P. Psutka, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 39:420-420
420 Background: To align BC treatment with patient goals, it is vital that healthcare providers (HCPs) engage their patients (pts) in SDM for treatment planning. We assessed alignment and discordances on aspects of SDM among BC pts and their urology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e42bbe3cdc1bd5af29c1a5e9543ec18c
https://doi.org/10.1200/jco.2021.39.6_suppl.420
https://doi.org/10.1200/jco.2021.39.6_suppl.420
Autor:
Maen A. Hussein, Rebecca R Crawford, Jeffrey D. Carter, Taral Patel, Tamar Sapir, Paul M. Barr, Servillano E. Dela Cruz, Michael J. Castine, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 38:231-231
231 Background: Though FL generally has good outcomes, patients with high risk FL have poorer outcomes; proper risk stratification for early intervention has been shown to improve overall benefit in some patients. In a quality improvement (QI) initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f0aaa24ca453e1fb7acd2043525c7d7
https://doi.org/10.1200/jco.2020.38.29_suppl.231
https://doi.org/10.1200/jco.2020.38.29_suppl.231
Publikováno v:
Journal of Clinical Oncology. 38:232-232
232 Background: For patients who have ALK or ROS1+ NSCLC, targeted therapies have greatly improved treatment options, though challenges personalizing care have hindered effective integration. In a quality improvement (QI) program conducted in 2 commu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd2ca85e29d054b6d46d4c328239f1f9
https://doi.org/10.1200/jco.2020.38.29_suppl.232
https://doi.org/10.1200/jco.2020.38.29_suppl.232
Publikováno v:
Journal of Clinical Oncology. 38:e19174-e19174
e19174 Background: Despite clinical evidence illustrating the efficacy of MT for ROC, complexities, such as patient-, treatment-, and disease-related factors, and team-based care coordination, limit its optimal use in ROC. In a quality improvement (Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b84d55024cc6b9b99f8934395fb52858
https://doi.org/10.1200/jco.2020.38.15_suppl.e19174
https://doi.org/10.1200/jco.2020.38.15_suppl.e19174
Publikováno v:
Journal of Clinical Oncology. 38:e19176-e19176
e19176 Background: In TNBC, ensuring patients understand their treatment options and engaging them in shared decision-making (SDM) is vital to patient centered care; however, system-, team-, and individual-level barriers may challenge optimal SDM. As
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59549e3d23409c2ee112fc4de58e35f9
https://doi.org/10.1200/jco.2020.38.15_suppl.e19176
https://doi.org/10.1200/jco.2020.38.15_suppl.e19176
Autor:
Eunice S. Wang, Jeffrey D. Carter, Taral Patel, Maen A. Hussein, Pavani Ellipeddi, Rebecca R Crawford, Tamar Sapir, Breanne Y Farris
Publikováno v:
Journal of Clinical Oncology. 38:e19172-e19172
e19172 Background: For AML patients who are ineligible for intensive induction, novel therapies have greatly improved treatment options, though practice challenges individualizing care have hindered effective integration. In a quality improvement (QI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a7c4e93d53707db4a8a392db9d7efd
https://doi.org/10.1200/jco.2020.38.15_suppl.e19172
https://doi.org/10.1200/jco.2020.38.15_suppl.e19172
ATP-binding cassette (ABC) transporters are transmembrane efflux transporters mediating the extrusion of an array of substrates ranging from amino acids and lipids to xenobiotics, and many therapeutic compounds, including anticancer drugs. The ABC tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac89ee801cef3ef102cf05aee9fe73a
https://europepmc.org/articles/PMC5896366/
https://europepmc.org/articles/PMC5896366/
Publikováno v:
The FASEB Journal. 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f58ee449d028cb0cd9fde36b95b362f6
https://doi.org/10.1096/fasebj.2018.32.1_supplement.695.15
https://doi.org/10.1096/fasebj.2018.32.1_supplement.695.15